Ensysce Biosciences
Ensysce Biosciences, La Jolla, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin-Activated Abuse Protection (TAAP) and Multi-Pill Abuse Resistance (MPAR) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
About Ensysce Biosciences
Founded
2008Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$121MCategory
Industry
BiotechnologyLocation
City
La JollaState
CaliforniaCountry
United StatesEnsysce Biosciences
Find your buyer within Ensysce Biosciences